Clinical trials recruiting for Dementia, Alzheimer Type
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Rifaximin SSD 40 mg IR tablet | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Florida | 1 |
| Louisiana | 1 |
| Virginia | 1 |
Top cities
Self-screener
Recruiting trials
- Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease
- Cervical Lymphatico-Venous Bypass for Treatment of Alzheimer's Disease - Proof of Concept Study (CLyVeB-AD-1 Study)
- Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
- Global Collaborative Research on Establishing a Korean Cognitive Aging Cohort
- Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)
- Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"
- Rifaximin SSD in Dementia Trial
- Validation of a Digital Intervention to Rehabilitate Cognitive Resources
Related conditions
Trials recruiting for Dementia, Alzheimer Type often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Dementia, Alzheimer Type trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.